 immunostaining node-negative stage I/II breast carcinoma Significant correlation prognosis Prognostic predictors node-negative breast carcinoma antibody frozen sections node-negative breast carcinomas patients prognostic value association clinicopathologic biochemical parameters patient age tumor size histologic type nuclear grade mitotic rate presence vascular lymphatic invasion DNA ploidy percentage cells S-phase estrogen content amplification tumors immunoreactivity antibody tumor cells significant correlation percentage nuclear grade age mitotic rate Nuclear anaplastic tumors median percentage cells median range nuclear grade tumors median range Thirteen patients recurrence disease univariate analysis disease-free overall survivals percentage cells antibody results immunostaining correlates nuclear grade clinical outcome node-negative breast carcinoma small sample size study unable analysis Therefore studies number cases tumor proliferative activity immunostaining independent prognostic parameter histopathologic features nuclear grade mitotic activity